Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression

Hongmin Li,Zhaofu Sheng,Suliman Khan,Ruiyi Zhang,Yang Liu,Yan Zhang,V. Wee Yong,Mengzhou Xue
DOI: https://doi.org/10.3389/fneur.2022.861843
IF: 3.4
2022-03-18
Frontiers in Neurology
Abstract:Matrix metalloproteinases (MMPs) are physiologically expressed in the central nervous system in neurons, astrocytes and microglia, and their aberrant elevation contributes to a number of diseases. Amongst the MMP members, MMP−9 has generated considerable attention because of its possible involvement in inflammatory responses, blood-brain barrier permeability, the regulation of perineuronal nets, demyelination, and synaptic long-term potentiation. Emerging evidence indicate an association between MMP−9 and the syndrome of depression. This review provides an updated and comprehensive summary of the probable roles of MMP−9 in depression with an emphasis on the mechanisms and potential of MMP−9 as a biomarker of depression.
neurosciences,clinical neurology
What problem does this paper attempt to address?